MKI-1, a Novel Small-Molecule Inhibitor of MASTL, Exerts Antitumor and Radiosensitizer Activities Through PP2A Activation in Breast CancerAh Young Kim, Jae‐Sung Kim|Frontiers in Oncology|2020Cited by 24